Search Results

with shared structure Impress Your Board and Your Team Walk into every update with a confident story, backed Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

. << Back to podcast list Strategic Partner(s) Antonella Di Pizio: Computational Pharmacology of Taste model, predict binding-site residues, send them out for mutagenesis, fold the experimental results back

. << Back to podcast list Strategic Partner(s) Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic It reframes the field's task from finding good targets to understanding the biology well enough to connect seller who supplied the compound disagreed, took naloxone, smoked salvia to disprove it, and emailed back project: a non-psychedelic psychedelic for depression 38:21 "I am not uncertain" — the data Bryan won't talk

<< Back to podcast list Strategic Partner(s) Dr.

. << Back to podcast list Strategic Partner(s) GPCR Assay Strategy, Bias, and Translational Drug Discovery

<< Back to podcast list Strategic Partner(s) Dr. Thomas P. Sakmar About Dr. Thomas P.

Fast-track your biotech investments with VC Insights. Fast Track My Discovery The wrong CRO—or wrong experiments—can burn months and millions You're not here You're backing science that needs to move fast. “The team’s updates sound polished, but we can’t tell if they’re on track.” I bring structure, decision frameworks, and momentum so your team stays on track.

When biotech partners trust your process, they come back again and again. Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

. << Back to podcast list Strategic Partner(s) Arun Shukla: How Two Arrestins Regulate 800 GPCRs The Shukla, the question of how two proteins manage 800 others isn't abstract — it's the one that pulled him back

. << Back to podcast list Strategic Partner(s) Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering For Cheloha, the motivation traces back to a habit he carried from childhood: writing reports on exotic About the Guest Ross Cheloha is a tenure-track investigator at the National Institute of Diabetes and

. << Back to podcast list Strategic Partner(s) Eleonora Comeo: Fluorescent Ligands and the Pharmacology than confirm receptor binding - they allow researchers to follow receptors through internalization, track resilience, collaboration, and not fearing the unknown 54:44 The dopamine rush that keeps scientists coming back

. << Back to podcast list Strategic Partner(s) Brian Arey - Part 2: GPCR Drug Discovery and the Science "I've spent 25 years pushing back against that. I feel like as scientists, we should be who we are.

. << Back to podcast list Strategic Partner(s) Alexander Hauser: GPCR Pharmacogenomics and Precision his integrative approach - bridging structural biology, evolutionary data, genetics, and psychiatry - back

Access 20+ on-demand GPCR courses, 200+ expert talks, weekly news, and a global scientist network. intelligence, live Masterclasses, job listings, events, and a community of scientists who have your back Join University — $499/year 1,400+ GPCR scientists reached 200+ Expert talks available $499 Per year Revisit the science at your pace — over 200 expert talks in the library and growing. Masterclasses cover a variety of track including but not limited to pharmacology foundations, agonists

. << Back to podcast list Strategic Partner(s) Chemical Probes for GPCR Imaging and Internalization with

. << Back to podcast list Strategic Partner(s) Why Mosquitoes Hunt You: GPCR Control of Blood Feeding Laura Duvall, whose research tracks the molecular mechanisms that govern mosquito behavior, focusing

. << Back to podcast list Strategic Partner(s) From Rare Earth Probes to Internalization Assays: The Trinquet shares the inside story behind the development of pH Sense, Revvity’s latest innovation for tracking Why pH Sense enables high-throughput, no-wash tracking of GPCR internalization—even at endogenous expression

. << Back to podcast list Strategic Partner(s) Model. Predict. Discover. with Dr.

< Back to Webinars 📅 Tuesday, March 3, 2026 at 3:00:00 PM UTC 🤝 Webinar in collaboration with: Celtarys

. << Back to podcast list Strategic Partner(s) Elva Zhao: G Protein Regulation and Biased Signaling at organized each subsequent move she made, from Western to Monash, and from G proteins to receptors and back data, and build collaborations 57:58 Advice for trainees - staying curious, knowing your question, and talking

. << Back to podcast list Strategic Partner(s) Brian Arey: Discovering Signaling Bias at the FSH Receptor not surprised" 53:07 Advice for scientists - follow the data, trust your controls, stay humble, give back

<< Back to podcast list Strategic Partner(s) Dr. Roger Sunahara About Dr.

. << Back to podcast list Strategic Partner(s) Annette Gilchrist: Native Cell Systems, Biased Agonism Almost no company with an approved GPCR-targeting drug has gone back to look at what common receptor

. << Back to podcast list Strategic Partner(s) Robert J. The monkey's off my back.

<< Back to podcast list Strategic Partner(s) Dr. Alix A. J. Rouault About Dr. Alix A. J.

. << Back to podcast list Strategic Partner(s) Scaling GLP 1 Receptor Tools Through Academia Industry

<< Back to podcast list Strategic Partner(s) Dr. GPCR Team About Dr. Yamina Berchiche Dr. Yamina A. Associate at IQVIA and regulatory officer at the Food and Drug Authority (FDA) in Ghana, John has a proven track Further down the track, he aims to apply this knowledge to develop novel chemical treatments for neuronal

These industry-standard assays, designed for regulatory submissions, are backed by partnerships with

. << Back to podcast list Strategic Partner(s) Antony Boucard: Adhesion GPCRs and the Molecular Code students no one else was recruiting 01:00:00 Adhesion GPCRs — the receptor family that kept calling him back

We occasionally modify these policies, so please check back here for updates. the Feeds is for personal, non-commercial purposes only, (ii) your display of the Feed Content links back